Letter regarding levosimendan in a rat model of severe verapamil poisoning.
作者信息
Graudins Andis
出版信息
J Med Toxicol. 2009 Sep;5(3):175; author reply 176. doi: 10.1007/BF03161231.
Abstract
摘要
相似文献
1
Letter regarding levosimendan in a rat model of severe verapamil poisoning.
J Med Toxicol. 2009 Sep;5(3):175; author reply 176. doi: 10.1007/BF03161231.
2
Levosimendan does not improve survival time in a rat model of verapamil toxicity.
J Med Toxicol. 2009 Mar;5(1):3-7. doi: 10.1007/BF03160973.
3
Levosimendan in regional myocardial ischemia.
Cardiovasc Drugs Ther. 2002 Sep;16(5):379-81. doi: 10.1023/a:1022199932485.
4
Comparative hemodynamic effects of levosimendan alone and in conjunction with 4-aminopyridine or calcium chloride in a rodent model of severe verapamil poisoning.
J Med Toxicol. 2010 Jun;6(2):85-93. doi: 10.1007/s13181-010-0073-y.
5
Levosimendan as an Antidote in Experimental Calcium Channel Blocker Intoxication.
J Cardiovasc Pharmacol. 2024 Sep 1;84(3):340-346. doi: 10.1097/FJC.0000000000001612.
6
Biochemical properties of OR-1259--a positive inotropic and vasodilatory compound with an antiarrhythmic effect.
Adv Exp Med Biol. 1992;311:423. doi: 10.1007/978-1-4615-3362-7_63.
7
Systemic and coronary hemodynamic actions and left ventricular functional effects of levosimendan in conscious dogs.
J Cardiovasc Pharmacol. 1995 Aug;26(2):179-88. doi: 10.1097/00005344-199508000-00002.
8
Levosimendan, a new inotropic and vasodilator agent.
Anesthesiology. 2006 Mar;104(3):556-69. doi: 10.1097/00000542-200603000-00024.
9
Levosimendan use in several scenarios of acute heart failure.
Arq Bras Cardiol. 2008 Mar;90(3):211-5. doi: 10.1590/s0066-782x2008000300012.
10
Levosimendan attenuates pulmonary vascular remodeling.
Intensive Care Med. 2011 Aug;37(8):1368-77. doi: 10.1007/s00134-011-2254-9. Epub 2011 May 31.
本文引用的文献
1
Levosimendan does not improve survival time in a rat model of verapamil toxicity.
J Med Toxicol. 2009 Mar;5(1):3-7. doi: 10.1007/BF03160973.
2
Treatment of experimental verapamil poisoning with levosimendan utilizing a rodent model of drug toxicity.
Clin Toxicol (Phila). 2008 Jan;46(1):50-6. doi: 10.1080/15563650701665092.
3
Comparison between dobutamine and levosimendan for management of postresuscitation myocardial dysfunction.
Crit Care Med. 2005 Mar;33(3):487-91. doi: 10.1097/01.ccm.0000156241.55872.15.
4
Levosimendan interacts with potassium channel blockers in human saphenous veins.
Basic Clin Pharmacol Toxicol. 2004 Jun;94(6):271-3. doi: 10.1111/j.1742-7843.2004.pto940603.x.
Zotero 插件